Ethics and Challenges in Medical Writing and Drug Approval

This chapter explores the ethical complexities surrounding medical writers and their impact on research authenticity, alongside the contentious drug approval processes, particularly in oncology. It highlights the influence of financial incentives on clinical trials and the FDA's approval methods, revealing concerns over patient trust and the efficacy of approved medications. A call for reforms is made to prioritize integrity in healthcare and to improve research outcomes through impartial oversight.